至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

HIV-1 Vpr antagonizes cGAS sensing by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport

biorxiv. 2020; 
Hataf Khan,  Rebecca P. Sumner,  Jane Rasaiyaah,  Choon Ping Tan,  Maria Teresa Rodriguez-Plata,  Chris van Tulleken,  Douglas Fink,  Lorena Zuliani-Alvarez,  Lucy Thorne,  David Stirling,  Greg J. Towers
Products/Services Used Details Operation
Molecular Biology Reagents To make VSV-G pseudotyped HIV-1 GFP, each T150 flask was transfected with 2.5 µg of vesicular stomatitis virus-G glycoprotein encoding plasmid (pMDG) (Genscript), 2.5 µg of packaging plasmid, p8.91 (encoding Gag-Pol, Tat and Rev) or p8.2 (encoding Gag-Pol, Tat and Rev and Vif, Vpr, Vpu and Nef) (Zufferey et al., 1997), and 3.75 µg of GFP encoding genome plasmid (pCSGW) using 30 µl Fugene 6 in 500µl optimum. Get A Quote

摘要

HIV-1 must replicate in cells that are equipped to defend themselves from infection through the intracellular innate immune system. Hence, HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here we show that the HIV-1 Vpr protein antagonizes the stimulatory effect of a variety of pathogen associated molecular patterns, including cytoplasmic DNA, by inhibiting IRF3 and NF-κB nuclear transport. Both particle associated, and expressed Vpr, antagonized innate immune signaling. Phosphorylation of IRF3 at S396, but not S386, was also inhibited by Vpr. We provide evidence that Vpr interacts with karyopherins and disturbs thei... More

关键词